Related Experiment Video
Updated: Oct 16, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Exception-Status Listing: A Critical Pathway to Heart Transplantation for Adults With Congenital Heart Diseases
Aniket S Rali1, Sagar Ranka2, Jeremy A Mazurek3
1From the Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Insights
Adults with congenital heart disease awaiting heart transplants can use exception-status listing for timely access. This vital pathway helps overcome limitations of conventional therapies and improves transplant access for complex cases.
Area of Science:
- Cardiology
- Transplantation Medicine
- Congenital Heart Disease
Background:
- Adults with congenital heart disease (ACHD) often face challenges with conventional therapies for ventricular systolic dysfunction.
- Mechanical circulatory support can prioritize heart transplant recipients, leading to longer wait times and increased mortality for ACHD patients.
- Exception-status listing offers a crucial pathway for listing complex ACHD patients for heart transplantation at appropriate priority levels.
Purpose of the Study:
- To evaluate trends in the utilization of exception-status listing for adults with congenital heart disease (ACHD) on the heart transplant waitlist.
- To assess the impact of changes in the organ allocation system on the use of exception-status listing for ACHD patients.
- To highlight the importance of exception-status listing for ensuring timely heart transplantation access for ACHD.
Main Methods:
- Utilized the United Network for Organ Sharing (UNOS) registry for data retrieval.
- Analyzed trends in exception-status listing among adult congenital heart disease patients awaiting heart transplantation.
- Examined the temporal relationship between exception-status listing trends and modifications to the organ allocation system.
Main Results:
- An upward trend in the use of exception-status listing was observed among ACHD patients.
- This uptrend in exception-status listing use was most pronounced following changes implemented in the organ allocation system.
- Exception-status listing has become an increasingly vital pathway for ACHD patients needing heart transplants.
Conclusions:
- Exception-status listing is a critical pathway for adults with congenital heart disease to access heart transplantation.
- The use of exception-status listing has increased, particularly after recent updates to the organ allocation system.
- This listing status is essential for ACHD patients whose waitlist mortality risks may not be adequately captured by standard criteria, ensuring timely access to transplants.
Abstract:
Adults with congenital heart diseases may not be candidates for conventional therapies to control ventricular systolic dysfunction, including mechanical circulatory support, which moves potential heart-transplantation recipients to a listing status of higher priority. This results in longer waitlist times and greater mortality rates. Exception-status listing allows a pathway for this complex and anatomically heterogenous group of patients to be listed for heart transplantation at appropriately high listing status. Our study queried the United Network for Organ Sharing registry to evaluate trends in the use of exception-status listing among adults with congenital heart diseases awaiting heart transplantation. Uptrend in the use of exception-status listing precedes the new allocation system, but it has been greatest since changes were made in the allocation system. It continues to remain a vital pathway for adults with congenital heart disease (whose waitlist mortality rates are often not characterized adequately by using the waitlist-status criteria) timely access to heart transplantation.
More Related Videos
08:30A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
Published on: February 14, 2022
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Kidney Transplant I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiac Catheterization I: Pre-Procedure Overview